World TB Day: What does COVID-19 mean for people with TB?
Around 10 million people get sick with TB every year. On World TB Day Amy Green asks what COVID-19 means for this group of people.
TB in children: The amazing research being done in Cape Town
Medicines that taste like strawberries or mangos, cutting edge trials on preventing TB in kids, measuring how children’s bodies take up TB medicines – in this World TB Day feature Kathryn Cleary profiles the amazing research done by the Desmond Tutu TB Centre in Cape Town.
US invests more in TB research, SA investment drops, report finds
In 2018 the United States invested $371 million in tuberculosis research and development (R&D). South Africa invested $4.5 million (R64,9 million) – a dramatic decrease on 2017, but still high when measured as a proportion of all R&D spending in the country.
Analysis: SA secures good prices for TB medicines, with one exception
With one puzzling exception, South Africa’s new tender prices for tuberculosis medicines appear to compare well with the lowest international prices.
Opinion: Approval of new TB drug lays bare crisis in TB research
While a combination of drugs including now FDA-approved pretomanid is probably the best treatment for XDR-TB, it is still not clear whether or not pretomanid itself is safe and effective.
New tuberculosis medicine studied in South Africa approved in United States
The new tuberculosis medicine pretomanid has just been registered by the United States Food and Drug Administration. What are the implications for South Africa?